logo

17.8

17.80 (0.45%)

As of Mar 06, 2024

Morphosys Ag [MOR]

Source: 

Company Overview

Morphosys Ag is a commercial-stage biopharmaceutical company devoted to the development and commercialization of innovative therapies for patients, with a focus on cancer. We have a broad pipeline in which we invest in and develop product candidates primarily in the hematology/oncology area. In 2022, we focused on commercializing our marketed product and in advancing product candidates at various stages of development.

CountryGermany
Headquartersplanegg
Phone Number49 89 89927-0
Industry
manufacturing
CEOJean-Paul Kress, M.D. Lucinda Crabtree, Ph.D.
Websitewww.morphosys.com